O	O	O	0	12	Contribution	Contribution	B-NP	NN	O	23	NMOD	O
O	O	O	13	15	of	of	B-PP	IN	O	1	NMOD	O
O	O	O	16	18	NF	NF	B-NP	NN	B-protein	6	NMOD	B-protein
O	O	O	18	19	-	-	B-NP	HYPH	I-protein	6	NMOD	I-protein
O	O	O	19	24	kappa	kappa	I-NP	NN	I-protein	6	NMOD	I-protein
O	O	O	25	26	B	B	I-NP	NN	I-protein	8	NMOD	I-protein
O	O	O	27	30	and	and	O	CC	O	8	NMOD	O
T1	B-Protein	B-Protein	31	34	Sp1	Sp1	B-NP	NN	B-DNA	10	NMOD	B-DNA
T5	B-Entity	B-Entity	35	42	binding	binding	B-NP	NN	I-DNA	10	NMOD	I-DNA
T5	I-Entity	I-Entity	43	49	motifs	motif	I-NP	NNS	I-DNA	2	PMOD	I-DNA
O	O	O	50	52	to	to	B-PP	TO	O	1	NMOD	O
O	O	O	53	56	the	the	B-NP	DT	O	14	NMOD	O
O	O	O	57	68	replicative	replicative	I-NP	JJ	O	14	NMOD	O
O	O	O	69	77	capacity	capacity	I-NP	NN	O	11	PMOD	O
O	O	O	78	80	of	of	B-PP	IN	O	14	NMOD	O
O	O	O	81	86	human	human	B-NP	JJ	O	19	NMOD	O
O	O	O	87	103	immunodeficiency	immunodeficiency	I-NP	NN	O	19	NMOD	O
O	O	O	104	109	virus	virus	I-NP	NN	O	19	NMOD	O
O	O	O	110	114	type	type	I-NP	NN	O	15	PMOD	O
O	O	O	115	116	1	1	I-NP	CD	O	19	NMOD	O
O	O	O	116	117	:	:	O	:	O	1	P	O
O	O	O	118	126	distinct	distinct	B-NP	JJ	O	23	NMOD	O
O	O	O	127	135	patterns	pattern	I-NP	NNS	O	27	SUB	O
O	O	O	136	138	of	of	B-PP	IN	O	23	NMOD	O
O	O	O	139	144	viral	viral	B-NP	JJ	O	26	NMOD	O
O	O	O	145	151	growth	growth	I-NP	NN	O	24	PMOD	O
O	O	O	152	155	are	be	B-VP	VBP	O	0	ROOT	O
O	O	O	156	166	determined	determine	I-VP	VBN	O	27	VC	O
O	O	O	167	169	by	by	B-PP	IN	O	28	VMOD	O
O	O	O	170	171	T	T	B-NP	NN	B-cell_type	33	NMOD	B-cell_type
O	O	O	171	172	-	-	I-NP	HYPH	I-cell_type	33	NMOD	I-cell_type
O	O	O	172	176	cell	cell	I-NP	NN	I-cell_type	33	NMOD	I-cell_type
O	O	O	177	182	types	type	I-NP	NNS	I-cell_type	29	PMOD	I-cell_type
O	O	O	182	183	.	.	O	.	O	27	P	O

O	O	O	185	193	Starting	Start	B-VP	VBG	O	54	VMOD	O
O	O	O	194	198	with	with	B-PP	IN	O	1	VMOD	O
O	O	O	199	200	a	a	B-NP	DT	O	4	NMOD	O
O	O	O	201	212	replication	replication	I-NP	NN	O	8	NMOD	O
O	O	O	212	213	-	-	B-NP	HYPH	O	8	NMOD	O
O	O	O	213	224	incompetent	incompetent	I-NP	JJ	O	8	NMOD	O
O	O	O	225	234	molecular	molecular	I-NP	JJ	O	8	NMOD	O
O	O	O	235	240	clone	clone	I-NP	NN	O	2	PMOD	O
O	O	O	241	243	of	of	B-PP	IN	O	8	NMOD	O
O	O	O	244	249	human	human	B-NP	JJ	O	13	NMOD	O
O	O	O	250	266	immunodeficiency	immunodeficiency	I-NP	NN	O	13	NMOD	O
O	O	O	267	272	virus	virus	I-NP	NN	O	13	NMOD	O
O	O	O	273	277	type	type	I-NP	NN	O	9	PMOD	O
O	O	O	278	279	1	1	I-NP	CD	O	13	NMOD	O
O	O	O	279	280	,	,	O	,	O	8	P	O
O	O	O	281	288	lacking	lack	B-VP	VBG	O	8	NMOD	O
O	O	O	289	292	all	all	B-NP	PDT	O	26	NMOD	O
O	O	O	293	296	the	the	I-NP	DT	O	26	NMOD	O
O	O	O	297	299	NF	NF	I-NP	NN	B-DNA	22	NMOD	B-DNA
O	O	O	299	300	-	-	B-NP	HYPH	I-DNA	22	NMOD	I-DNA
O	O	O	300	305	kappa	kappa	I-NP	NN	I-DNA	22	NMOD	I-DNA
O	O	O	306	307	B	B	I-NP	NN	I-DNA	24	NMOD	I-DNA
O	O	O	308	311	and	and	O	CC	I-DNA	24	NMOD	I-DNA
T2	B-Protein	B-Protein	312	315	Sp1	Sp1	B-NP	NN	I-DNA	26	NMOD	I-DNA
T6	B-Entity	B-Entity	316	323	binding	binding	B-NP	NN	I-DNA	26	NMOD	I-DNA
T6	I-Entity	I-Entity	324	329	sites	site	I-NP	NNS	I-DNA	16	OBJ	I-DNA
O	O	O	330	337	present	present	B-ADJP	JJ	O	26	NMOD	O
O	O	O	338	340	in	in	B-PP	IN	O	27	AMOD	O
O	O	O	341	344	the	the	B-NP	DT	O	33	NMOD	O
T7	B-Entity	B-Entity	345	351	native	native	I-NP	JJ	B-DNA	33	NMOD	B-DNA
T7	I-Entity	I-Entity	352	356	long	long	I-NP	JJ	I-DNA	33	NMOD	I-DNA
T7	I-Entity	I-Entity	357	365	terminal	terminal	I-NP	JJ	I-DNA	33	NMOD	I-DNA
T7	I-Entity	I-Entity	366	372	repeat	repeat	I-NP	NN	I-DNA	28	PMOD	I-DNA
O	O	O	373	374	(	(	O	(	O	36	DEP	O
T8	B-Entity	B-Entity	374	377	LTR	LTR	B-NP	NN	B-DNA	36	DEP	B-DNA
O	O	O	377	378	)	)	O	)	O	33	NMOD	O
O	O	O	378	379	,	,	O	,	O	54	P	O
O	O	O	380	390	proviruses	provirus	B-NP	NNS	O	54	SUB	O
O	O	O	391	401	containing	contain	B-VP	VBG	O	38	NMOD	O
T9	B-Entity	B-Entity	402	415	reconstructed	reconstruct	B-NP	VBN	B-DNA	41	NMOD	B-DNA
T9	I-Entity	I-Entity	416	420	LTRs	LTR	I-NP	NNS	I-DNA	39	OBJ	I-DNA
O	O	O	421	425	with	with	B-PP	IN	O	41	NMOD	O
O	O	O	426	436	individual	individual	B-NP	JJ	O	45	NMOD	O
O	O	O	437	439	or	or	O	CC	O	45	NMOD	O
O	O	O	440	452	combinations	combination	B-NP	NNS	O	42	PMOD	O
O	O	O	453	455	of	of	B-PP	IN	O	45	NMOD	O
O	O	O	456	458	NF	NF	B-NP	NN	O	52	NMOD	O
O	O	O	458	459	-	-	B-NP	HYPH	O	52	P	O
O	O	O	459	464	kappa	kappa	I-NP	NN	B-DNA	50	NMOD	B-DNA
O	O	O	465	466	B	B	I-NP	NN	I-DNA	52	NMOD	I-DNA
O	O	O	467	470	and	and	O	CC	I-DNA	52	NMOD	I-DNA
T3	B-Protein	B-Protein	471	474	Sp1	Sp1	B-NP	NN	I-DNA	53	NMOD	I-DNA
T10	B-Entity	B-Entity	475	483	elements	element	B-NP	NNS	I-DNA	46	PMOD	I-DNA
O	O	O	484	488	were	be	B-VP	VBD	O	0	ROOT	O
O	O	O	489	498	generated	generate	I-VP	VBN	O	54	VC	O
O	O	O	499	502	and	and	O	CC	O	55	VMOD	O
O	O	O	503	512	evaluated	evaluate	B-VP	VBN	O	55	VMOD	O
O	O	O	513	516	for	for	B-PP	IN	O	57	VMOD	O
O	O	O	517	522	their	their	B-NP	PRP$	O	60	NMOD	O
O	O	O	523	531	capacity	capacity	I-NP	NN	O	58	PMOD	O
O	O	O	532	534	to	to	B-VP	TO	O	62	VMOD	O
O	O	O	535	542	produce	produce	I-VP	VB	O	60	NMOD	O
O	O	O	543	548	virus	virus	B-NP	NN	O	64	NMOD	O
O	O	O	549	556	progeny	progeny	I-NP	NN	O	62	OBJ	O
O	O	O	557	566	following	follow	B-PP	VBG	O	62	VMOD	O
O	O	O	567	579	transfection	transfection	B-NP	NN	O	68	NMOD	O
O	O	O	579	580	-	-	I-NP	HYPH	O	68	NMOD	O
O	O	O	580	593	cocultivation	cocultivation	I-NP	NN	O	65	PMOD	O
O	O	O	593	594	.	.	O	.	O	54	P	O

O	O	O	595	600	Virus	Virus	B-NP	NN	O	2	NMOD	O
O	O	O	601	607	stocks	stock	I-NP	NNS	O	7	SUB	O
O	O	O	608	616	obtained	obtain	B-VP	VBN	O	2	NMOD	O
O	O	O	617	621	from	from	B-PP	IN	O	3	VMOD	O
O	O	O	622	627	these	these	B-NP	DT	O	6	NMOD	O
O	O	O	628	639	experiments	experiment	I-NP	NNS	O	4	PMOD	O
O	O	O	640	649	exhibited	exhibit	B-VP	VBD	O	0	ROOT	O
O	O	O	650	651	a	a	B-NP	DT	O	9	NMOD	O
O	O	O	652	661	continuum	continuum	I-NP	NN	O	7	OBJ	O
O	O	O	662	664	of	of	B-PP	IN	O	9	NMOD	O
O	O	O	665	676	replicative	replicative	B-NP	JJ	O	12	NMOD	O
O	O	O	677	687	capacities	capacity	I-NP	NNS	O	10	PMOD	O
O	O	O	688	690	in	in	B-PP	IN	O	7	VMOD	O
O	O	O	691	700	different	different	B-NP	JJ	O	19	NMOD	O
O	O	O	701	706	human	human	I-NP	JJ	B-cell_type	19	NMOD	B-cell_type
O	O	O	707	708	T	T	I-NP	NN	I-cell_type	19	NMOD	I-cell_type
O	O	O	708	709	-	-	I-NP	HYPH	I-cell_type	19	NMOD	I-cell_type
O	O	O	709	713	cell	cell	I-NP	NN	I-cell_type	19	NMOD	I-cell_type
O	O	O	714	719	types	type	I-NP	NNS	I-cell_type	13	PMOD	I-cell_type
O	O	O	720	729	depending	depend	B-PP	VBG	O	19	NMOD	O
O	O	O	730	732	on	on	B-PP	IN	O	20	PMOD	O
O	O	O	733	738	which	which	B-NP	WDT	O	21	PMOD	O
T11	B-Entity	B-Entity	739	746	element	element	I-NP	NN	O	22	NMOD	O
O	O	O	746	747	(	(	I-NP	(	O	22	NMOD	O
O	O	O	747	748	s	s	I-NP	NNS	O	22	NMOD	O
O	O	O	748	749	)	)	O	)	O	22	NMOD	O
O	O	O	750	753	was	be	B-VP	VBD	O	22	SBAR	O
O	O	O	754	761	present	present	B-ADJP	JJ	O	27	PRD	O
O	O	O	762	764	in	in	B-PP	IN	O	28	AMOD	O
O	O	O	765	768	the	the	B-NP	DT	O	31	NMOD	O
T12	B-Entity	B-Entity	769	772	LTR	LTR	I-NP	NN	B-DNA	29	PMOD	B-DNA
O	O	O	772	773	.	.	O	.	O	7	P	O

O	O	O	774	777	For	For	B-PP	IN	O	52	VMOD	O
O	O	O	778	785	example	example	B-NP	NN	O	1	PMOD	O
O	O	O	785	786	,	,	O	,	O	52	P	O
O	O	O	787	789	in	in	B-PP	IN	O	52	VMOD	O
O	O	O	790	801	experiments	experiment	B-NP	NNS	O	4	PMOD	O
O	O	O	802	811	involving	involve	B-VP	VBG	O	5	NMOD	O
O	O	O	812	820	proviral	proviral	B-NP	JJ	O	8	NMOD	O
O	O	O	821	827	clones	clone	I-NP	NNS	O	6	OBJ	O
O	O	O	828	832	with	with	B-PP	IN	O	8	NMOD	O
T13	B-Entity	B-Entity	833	837	LTRs	LTR	B-NP	NNS	B-DNA	9	PMOD	B-DNA
O	O	O	838	848	containing	contain	B-VP	VBG	O	10	NMOD	O
O	O	O	849	852	one	one	B-NP	CD	O	14	AMOD	O
O	O	O	853	855	or	or	I-NP	CC	O	14	AMOD	O
O	O	O	856	859	two	two	I-NP	CD	O	11	OBJ	O
T14,T15	B-Entity,B-Entity	B-Entity,B-Entity	860	862	NF	NF	I-NP	NN	B-DNA	19	NMOD	B-DNA
T14,T15	I-Entity,I-Entity	I-Entity,I-Entity	862	863	-	-	I-NP	HYPH	I-DNA	19	NMOD	I-DNA
T14,T15	I-Entity,I-Entity	I-Entity,I-Entity	863	868	kappa	kappa	I-NP	NN	I-DNA	19	NMOD	I-DNA
T14,T15	I-Entity,I-Entity	I-Entity,I-Entity	869	870	B	B	I-NP	NN	I-DNA	19	NMOD	I-DNA
T14	I-Entity	I-Entity	871	879	elements	element	I-NP	NNS	I-DNA	14	NMOD	I-DNA
O	O	O	880	881	(	(	O	(	O	26	DEP	O
O	O	O	881	884	and	and	O	CC	O	25	NMOD	O
O	O	O	885	887	no	no	B-NP	DT	O	25	NMOD	O
T4	B-Protein	B-Protein	888	891	Sp1	Sp1	I-NP	NN	B-DNA	25	NMOD	B-DNA
T16	B-Entity	B-Entity	892	899	binding	binding	I-NP	NN	I-DNA	25	NMOD	I-DNA
T16	I-Entity	I-Entity	900	905	sites	site	I-NP	NNS	I-DNA	26	DEP	I-DNA
O	O	O	905	906	)	)	O	)	O	14	NMOD	O
O	O	O	906	907	,	,	O	,	O	52	P	O
O	O	O	908	909	a	a	B-NP	DT	O	29	NMOD	O
O	O	O	910	919	hierarchy	hierarchy	I-NP	NN	O	52	SUB	O
O	O	O	920	922	of	of	B-PP	IN	O	29	NMOD	O
O	O	O	923	931	cellular	cellular	B-NP	JJ	O	32	NMOD	O
O	O	O	932	944	permissivity	permissivity	I-NP	NN	O	30	PMOD	O
O	O	O	945	947	to	to	B-PP	TO	O	32	NMOD	O
O	O	O	948	953	virus	virus	B-NP	NN	O	35	NMOD	O
O	O	O	954	965	replication	replication	I-NP	NN	O	33	PMOD	O
O	O	O	966	967	(	(	O	(	O	51	DEP	O
O	O	O	967	977	peripheral	peripheral	B-NP	JJ	B-cell_type	39	NMOD	B-cell_type
O	O	O	978	983	blood	blood	I-NP	NN	I-cell_type	39	NMOD	I-cell_type
O	O	O	984	995	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	41	SUB	I-cell_type
O	O	O	996	997	=	=	B-VP	SYM	O	41	VMOD	O
O	O	O	998	1001	MT4	MT4	B-NP	NN	B-cell_line	51	DEP	B-cell_line
O	O	O	1002	1009	greater	great	B-ADJP	JJR	O	41	NMOD	O
O	O	O	1010	1014	than	than	B-PP	IN	O	42	AMOD	O
O	O	O	1015	1017	H9	H9	B-NP	NN	B-cell_line	43	PMOD	B-cell_line
O	O	O	1018	1025	greater	great	B-ADJP	JJR	O	44	NMOD	O
O	O	O	1026	1030	than	than	B-PP	IN	O	45	AMOD	O
O	O	O	1031	1034	CEM	CEM	B-NP	NN	B-cell_line	46	PMOD	B-cell_line
O	O	O	1035	1042	greater	great	B-ADJP	JJR	O	47	NMOD	O
O	O	O	1043	1047	than	than	B-PP	IN	O	48	AMOD	O
O	O	O	1048	1054	Jurkat	Jurkat	B-NP	NN	B-cell_line	49	PMOD	B-cell_line
O	O	O	1054	1055	)	)	O	)	O	32	NMOD	O
O	O	O	1056	1059	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1060	1068	observed	observe	I-VP	VBN	O	52	VC	O
O	O	O	1068	1069	.	.	O	.	O	52	P	O

O	O	O	1070	1072	Of	Of	B-PP	IN	O	3	PRD	O
O	O	O	1073	1077	note	note	B-NP	NN	O	1	PMOD	O
O	O	O	1078	1081	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1082	1085	the	the	B-NP	DT	O	6	NMOD	O
O	O	O	1086	1096	associated	associate	I-NP	VBN	O	6	NMOD	O
O	O	O	1097	1106	emergence	emergence	I-NP	NN	O	3	PRD	O
O	O	O	1107	1109	of	of	B-PP	IN	O	6	NMOD	O
T17	B-Entity	B-Entity	1110	1116	second	second	B-NP	JJ	O	12	NMOD	O
T17	I-Entity	I-Entity	1116	1117	-	-	I-NP	HYPH	O	12	P	O
T17	I-Entity	I-Entity	1117	1121	site	site	I-NP	NN	O	12	NMOD	O
T17	I-Entity	I-Entity	1122	1125	LTR	LTR	I-NP	NN	O	12	NMOD	O
O	O	O	1126	1136	revertants	revertant	I-NP	NNS	O	7	PMOD	O
O	O	O	1137	1142	which	which	B-NP	WDT	O	6	NMOD	O
O	O	O	1143	1151	involved	involve	B-VP	VBD	O	13	SBAR	O
O	O	O	1152	1154	an	an	B-NP	DT	O	16	NMOD	O
O	O	O	1155	1165	alteration	alteration	I-NP	NN	O	14	OBJ	O
O	O	O	1166	1168	of	of	B-PP	IN	O	16	NMOD	O
O	O	O	1169	1172	the	the	B-NP	DT	O	20	NMOD	O
T18	B-Entity	B-Entity	1173	1177	TATA	TATA	I-NP	NN	B-DNA	20	NMOD	B-DNA
T18	I-Entity	I-Entity	1178	1181	box	box	I-NP	NN	I-DNA	17	PMOD	I-DNA
O	O	O	1181	1182	.	.	O	.	O	3	P	O

O	O	O	1183	1188	These	These	B-NP	DT	O	2	NMOD	O
O	O	O	1189	1196	results	result	I-NP	NNS	O	3	SUB	O
O	O	O	1197	1204	suggest	suggest	B-VP	VBP	O	0	ROOT	O
O	O	O	1205	1209	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	O	1210	1213	the	the	B-NP	DT	O	11	NMOD	O
T19	B-Entity	B-Entity	1214	1219	human	human	I-NP	JJ	B-DNA	11	NMOD	B-DNA
T19	I-Entity	I-Entity	1220	1236	immunodeficiency	immunodeficiency	I-NP	NN	I-DNA	11	NMOD	I-DNA
T19	I-Entity	I-Entity	1237	1242	virus	virus	I-NP	NN	I-DNA	11	NMOD	I-DNA
T19	I-Entity	I-Entity	1243	1247	type	type	I-NP	NN	I-DNA	11	NMOD	I-DNA
T19	I-Entity	I-Entity	1248	1249	1	1	I-NP	CD	I-DNA	11	NMOD	I-DNA
T19	I-Entity	I-Entity	1250	1253	LTR	LTR	I-NP	NN	I-DNA	12	SUB	I-DNA
O	O	O	1254	1263	possesses	possess	B-VP	VBZ	O	4	SBAR	O
O	O	O	1264	1274	functional	functional	B-NP	JJ	O	14	NMOD	O
O	O	O	1275	1285	redundancy	redundancy	I-NP	NN	O	12	OBJ	O
O	O	O	1286	1291	which	which	B-NP	WDT	O	14	NMOD	O
O	O	O	1292	1299	ensures	ensure	B-VP	VBZ	O	15	SBAR	O
O	O	O	1300	1305	virus	virus	B-NP	NN	O	18	NMOD	O
O	O	O	1306	1317	replication	replication	I-NP	NN	O	16	OBJ	O
O	O	O	1318	1320	in	in	B-PP	IN	O	18	NMOD	O
O	O	O	1321	1330	different	different	B-NP	JJ	O	24	NMOD	O
O	O	O	1331	1332	T	T	I-NP	NN	B-cell_type	24	NMOD	B-cell_type
O	O	O	1332	1333	-	-	B-NP	HYPH	I-cell_type	24	NMOD	I-cell_type
O	O	O	1333	1337	cell	cell	I-NP	NN	I-cell_type	24	NMOD	I-cell_type
O	O	O	1338	1343	types	type	I-NP	NNS	I-cell_type	19	PMOD	I-cell_type
O	O	O	1344	1347	and	and	O	CC	O	16	VMOD	O
O	O	O	1348	1350	is	be	B-VP	VBZ	O	16	VMOD	O
O	O	O	1351	1358	capable	capable	B-ADJP	JJ	O	26	PRD	O
O	O	O	1359	1361	of	of	B-PP	IN	O	27	AMOD	O
O	O	O	1362	1370	changing	change	B-VP	VBG	O	28	PMOD	O
O	O	O	1371	1380	depending	depend	B-PP	VBG	O	27	AMOD	O
O	O	O	1381	1383	on	on	B-PP	IN	O	30	PMOD	O
O	O	O	1384	1387	the	the	B-NP	DT	O	34	NMOD	O
O	O	O	1388	1398	particular	particular	I-NP	JJ	O	34	NMOD	O
O	O	O	1399	1410	combination	combination	I-NP	NN	O	31	PMOD	O
O	O	O	1411	1413	of	of	B-PP	IN	O	34	NMOD	O
O	O	O	1414	1429	transcriptional	transcriptional	B-NP	JJ	B-protein	37	NMOD	B-protein
O	O	O	1430	1437	factors	factor	I-NP	NNS	I-protein	35	PMOD	I-protein
O	O	O	1438	1445	present	present	B-ADJP	JJ	O	37	NMOD	O
O	O	O	1445	1446	.	.	O	.	O	3	P	O
